Lichter Jay
Janux Therapeutics, Inc. · Director, 10% Owner
Lichter Jay is listed in filings as Director, 10% Owner at Janux Therapeutics, Inc.. This profile follows SEC Form 4 activity through Oct 24, 2024, including sale activity. Recent filings connect the profile to Janux Therapeutics, Inc. (JANX). The current snapshot covers public activity from Jun 28, 2024 to Oct 24, 2024. Reported amounts are shown as $332.3K to $15.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $178k3.8k shares | SellSep 13, 2024 | $46.68 | $15.84 |